{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:36:45Z","timestamp":1791419805282,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jdcr.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T02:29:20Z","timestamp":1682476160000},"page":"16-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus"],"prefix":"10.1016","volume":"37","author":[{"given":"Soundos","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Bordone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2023.04.017_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-4632.2009.04062.x","article-title":"Lichen planus","volume":"48","author":"Lehman","year":"2009","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2023.04.017_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMcp1103641","article-title":"Clinical practice. Lichen planus","volume":"366","author":"Le Cleach","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jdcr.2023.04.017_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaad.2019.04.027","article-title":"Clinical epidemiology and treatment of lichen planus: a retrospective review of 2 tertiary care centers","volume":"81","author":"Schwager","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.04.017_bib4","first-page":"309","article-title":"Clinical variants of lichen planus","volume":"11","author":"Wagner","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"10.1016\/j.jdcr.2023.04.017_bib5","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/1346-8138.16191","article-title":"Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: results from a single-center study","volume":"48","author":"Boch","year":"2021","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2023.04.017_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000494613","article-title":"Janus kinase inhibitors for the treatment of severe alopecia areata: an open-label comparative study","volume":"235","author":"Almutairi","year":"2019","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.jdcr.2023.04.017_bib7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/jdv.18263","article-title":"The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - a network meta-analysis","volume":"36","author":"Zhang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jdcr.2023.04.017_bib8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2020.01.031","article-title":"Treatment of severe lichen planus with the JAK inhibitor tofacitinib","volume":"145","author":"Damsky","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"10.1016\/j.jdcr.2023.04.017_bib9","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3585","article-title":"Tofacitinib in hypertrophic lichen planus","volume":"100","author":"Seiringer","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdcr.2023.04.017_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/12034754231156100","article-title":"The use of Janus kinase inhibitors for lichen planus: an evidence-based review","author":"Abduelmula","year":"2023","journal-title":"J Cutan Med Surg"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:23Z","timestamp":1762475123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"alternative-id":["S2352512623001340"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.04.017","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}